ArticleMolecular cancer therapeutics2022

Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.

William G Rice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.